Association between race, hospital volume of major liver surgery and access to metastasectomy for colorectal liver metastases

نویسندگان

چکیده

Presenter: Annabelle Jones MD | Brigham and Women's Hospital Background: In select patients with colorectal cancer liver metastases (CRLM), metastasectomy curative-intent has been found to be associated a 5-year overall survival that is greater than 50%. Despite recent advancements, it estimated only half of potentially resectable CRLM are undergoing metastasectomy. Previous studies have demonstrated non-White were significantly less likely undergo as compared White patients. Additionally, hospital variation in access volume surgery medical care for the primary site. The aim this study evaluate differences according hospital-year (HVLS). We hypothesized would HVLS, racial lower hospitals highest HVLS. Methods: National Cancer Database (NCDB) Colon, Rectosigmoid Junction Rectum data (2011-2017) used identify confirmed histology adenocarcinoma who underwent site surgical resection had without evidence extra-hepatic disease. Using 2011-2017 Liver NCDB, stratified into quartiles HVLS included formal extended hepatectomy transplants. A Poisson regression model adjusted age, gender, Charlson-Deyo score, insurance type, facility income quartiles, treatment at multiple facilities, margin, nodal, systemic therapy status was interaction between race (lowest highest) Results: identified 27,342 (median age 60, IQR 51-70, 55.6% male, 82.9% White, 17.2% non-White) CRLM. majority did not (n = 20,714, 76%). Of 6,628 treated metastasectomy, 45.4% 3,009) perform any major surgery. Overall, after adjusting potential confounders (RR 0.88, 95% CI 0.82-0.95, p 0.001). Additional patient factors likelihood Medicaid insurance, being uninsured, positive margin cancer. Among quartile hospitals, 0.84, 0.73-0.97, 0.017, Table). lowest (Table). Conclusion: Undergoing where received their care. Although translate equal Racial disparities persist CRLM, future research needed develop innovative strategies address disparity accessing

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases.

BACKGROUND The liver is the most common site of metastases for colorectal cancer, and combined resection with systemic chemotherapy is the most effective strategy for survival. The aim of this article is to provide a comprehensive summary on four hot topics related to chemotherapy and surgery for colorectal liver metastases (CLM), namely: (1) chemotherapy-related liver injuries: prediction and ...

متن کامل

Resection for Colorectal Liver Metastases

Colorectal cancer is the third most frequent cancer in the Western world. About half of the patients develop synchronous or metachronous metastases. The liver is the most common site of such metastases and thus hepatic metastatic disease is a significant socio-medical problem. If it is not treated, the median patient survival is only some months. Surgical resection is the treatment of choice fo...

متن کامل

Liver resection for colorectal metastases.

PURPOSE More than 50,000 patients in the United States will present each year with liver metastases from colorectal cancers. The current study was performed to determine if liver resection for colorectal metastases is safe and effective and to evaluate predictors of outcome. MATERIALS AND METHODS Data for 456 consecutive resections performed between July 1985 and December 1991 in a tertiary r...

متن کامل

Colorectal liver metastases.

BACKGROUND Despite major advances in therapies for liver metastases, colorectal cancer remains one of the commonest causes of cancer-related deaths in the UK. SOURCES OF DATA The international literature on the management of colorectal liver metastases (CLM) was reviewed. AREAS OF AGREEMENT Due to a combination of highly active systemic agents and low perioperative mortality achieved by hig...

متن کامل

Colorectal liver metastases

Each year in the UK, between 1214 000 people develop liver metastases from colorectal cancer. These metastases will contribute to the death ofthe patient in about 80% ofcases. Treatments aimed at these tumours are best administered when the tumour is small. Current investigative methods allow tumours as small as 0.5 mm to be detected, and should be offered to all colorectal cancer patients at r...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Hpb

سال: 2021

ISSN: ['1365-182X', '1477-2574']

DOI: https://doi.org/10.1016/j.hpb.2021.06.066